An internal Cutter memo recorded that although "Cutter will only sell 100% screened material" nonetheless "some Centre Directors are happy to use up their existing stock of unscreened Koate HT."
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation